-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.00800% Upside
Coherus BioSciences, Inc. Frequently Asked Questions
-
What analysts cover Coherus BioSciences, Inc.?
Coherus BioSciences, Inc. has been rated by research analysts at J.P. Morgan, UBS in the past 90 days.